KeepBio
KeepBio provides a proprietary, human-milk-inspired medical nutrition therapy designed to restore the gut microbiome in vulnerable patients following antibiotic treatment. The therapy is intended to be administered alongside antibiotics to help reduce the risk of healthcare-associated infections, which claim over 100,000 lives annually in the U.S. The company's vision is to make microbiome restoration a routine part of antibiotic care for the tens of millions of patients who receive antibiotics each year.
- Healthcare Technology
- Biotechnology
Funding
Founders
Founder details are not available yet.
Product
Problem
More than 100,000 people in the U.S. die each year from healthcare-associated infections. Growing evidence suggests that disruption of the protective gut microbiome during antibiotic treatment may contribute to infection risk in vulnerable patients.
Solution
KeepBio provides a proprietary, human-milk-inspired medical nutrition therapy designed to support restoration of the gut microbiome following antibiotic treatment. The therapy is intended to be used alongside antibiotics—not in place of them—to help close the nutritional gap created by antibiotics and support the microbiome's natural protective functions. By rebuilding a healthy gut microbiome, KeepBio aims to reduce the risk of healthcare-associated infections in vulnerable patients. The company's vision is to make microbiome restoration a routine part of antibiotic care for the tens of millions of patients who receive antibiotics every year.
Target Audience
Primary customers are healthcare providers and institutions caring for vulnerable patients who are receiving antibiotic treatment and are at risk of healthcare-associated infections.
Features
- Proprietary, human-milk-inspired medical nutrition therapy formulation
- Designed specifically to be administered alongside antibiotics
- Targets restoration of the gut microbiome's protective functions
- Developed to address the nutritional gap created by antibiotic treatment
- Intended for use in vulnerable patient populations